Clinical trials: Supraventricular Tachycardias
SVT
Differentiate AVNRT from Orthodromic AVRT
To study new maneuvers to differentiate AVNRT from orthodromic AVRT including VA interval variability at tachycardia induction, SA-VA base and local VA index (difference between local VA interval, measured on the coronary sinus…
- Trial name
- NCT06671145
- Testing
- catheter ablation
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Assiut University
Supraventricular Tachycardia
Using Non-Fluoroscopic Imaging Devices to Decrease Radiation Exposure During Ablation of Supraventricular Tachycardia
The purpose of this study is to determine whether the additional use of non-fluoroscopic imaging modalities can decrease the use of radiation exposure during standard ablation procedures for supraventricular tachycardia (SVT) in…
- Trial name
- NCT00979303
- Testing
- Intracardiac echocardiography and 3D navigational system
- Where
- United States
- Volunteers
- 74 people
- Sponsor
- Boston Children's Hospital
Paroxysmal Supraventricular Tachycardia
Zero-fluoroscopy Approach Versus Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia
This study is aimed to compare the feasibility, safety and efficacy of a zero-fluoroscopic approach using Ensite NavX with conventional fluoroscopic approach using Ensite NavX plus fluoroscopy for the ablation of paroxysmal…
- Trial name
- ZFA-PSVT (NCT03042078)
- Testing
- Zero-fluoroscopic ablation, Conventional fluoroscopic ablation
- Where
- China
- Volunteers
- 3,060 people
- Sponsor
- Tongji Hospital
Paroxysmal Supraventricular Tachycardia (PSVT)
The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry.
Paroxysmal supraventricular tachycardia (PSVT) is a sporadic, sudden, and recurring tachycardia that is caused by an altered electrical conductivity in the heart.
- Trial name
- NCT03353610
- Where
- United States
- Volunteers
- 354 people
- Sponsor
- Milestone Pharmaceuticals Inc.
Paroxysmal Supraventricular Tachycardia
Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia（PSVT）
The purpose of this study was to explore the safety and efficacy of a Pulsed Field Ablation Device and Force Sensing Pulsed Field Ablation Catheter in the treatment of Paroxysmal Supraventricular Tachycardia.
- Trial name
- NCT05770921
- Testing
- Pulsed Field Ablation Device and Force Sensing Pulsed Field Ablation Catheter
- Where
- China
- Volunteers
- 10 people
- Sponsor
- Ningbo No. 1 Hospital
Atrial Fibrillation, Tachycardia, Supraventricular
Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT)
The purpose of this study is to find out if specialized programs in the AT500 and EnRhythm pacemakers will reduce the number of irregular heartbeat in the upper chamber of the heart and reduce symptoms (such as shortness of…
- Conditions
- Atrial Fibrillation, Tachycardia, Supraventricular, Arrhythmia, Bradycardia
- Trial name
- NCT00289289
- Testing
- Intervention Pacing Features
- Where
- 38 sites in United States, Canada
- Volunteers
- 400 people
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure
Supraventricular Arrhythmias, Children
Management of Supraventricular Tachycardias in Children
Background Supraventricular tachycardias (SVTs) are the most common arrhythmic events in children, with an estimated incidence of 13 per 100,000 per year before the age of 18.
- Conditions
- Supraventricular Arrhythmias, Children, Management
- Trial name
- NCT07291544
- Testing
- Management of children with supraventricular tachycardias
- Volunteers
- 1,400 people
- Sponsor
- Paris Cardiovascular Research Center (Inserm U970)
Supraventricular Tachycardia (SVT)
A Novel Valsalva Assist Device for Terminating Supraventricular Tachycardia
The goal of this clinical trial is to evaluate the efficiency of a device for terminating supraventricular tachycardia. The main questions it aims to answer are: The Valsalva manoeuvre is a first-line treatment for…
- Trial name
- NCT06622772
- Testing
- Valsalva assist device, standard Valsalva manoeuvre
- Where
- China
- Volunteers
- 212 people
- Sponsor
- Beijing Anzhen Hospital
Supraventricular Tachycardia
Treatment Study of AV Node Reentry Tachycardia
Compare the effectiveness and safety of two techniques for modification of slow AV nodal pathway conduction underlying AVNRT: 1) New Ablation Technique, low voltage and wave front collision mapping vs.
- Trial name
- AVNRT (NCT04232371)
- Testing
- New Ablation Technique, Standard Ablation Technique
- Where
- 5 sites in United States
- Volunteers
- 300 people
- Sponsor
- Jeffrey Moak
Paroxysmal Supraventricular Tachycardia
Study on Left Atrial Function of Paroxysmal Supraventricular Tachycardia After Radiofrequency Ablation
This study to investigate the effects of RF ablation on left atrial systolic function in patients with atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular tachycardia (AVRT).
- Trial name
- NCT03348436
- Testing
- radiofrequency ablation
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Ruiqin xie
Fetal Atrial Flutter Without Hydrops, Fetal Supraventricular Tachycardia Without Hydrops
Prospective Randomized Clinical Trial of Fetal Atrial Flutter & Supraventricular Tachycardia Therapy (FAST RCT)
The Fetal Atrial Flutter and Supraventricular Tachycardia (FAST) Therapy Trial is a prospective multi-center trial that examines the efficacy and safety of standard prenatal antiarrhythmic treatment.
- Conditions
- Fetal Atrial Flutter Without Hydrops, Fetal Supraventricular Tachycardia Without Hydrops, Fetal Supraventricular Tachycardia With Hydrops
- Trial name
- NCT02624765
- Testing
- Digoxin (monotherapy), Sotalol (monotherapy), Flecainide (monotherapy)
- Where
- 22 sites in United States, Australia and 4 more
- Volunteers
- 105 people
- Sponsor
- Edgar Jaeggi
Supraventricular Tachycardia
Dexmedetomidine and Adenosine: Therapeutic Use for SVT
The purpose of this study is to evaluate the efficacy and safety of dexmedetomidine in the acute termination of Supraventricular Tachycardia (SVT).
- Trial name
- NCT01495481
- Testing
- Dexmedetomidine, Adenosine
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- University of Pittsburgh
Presyncope, Arrhythmias, Cardiac
The IPED (Investigation of Palpitations in the ED) Study
Palpitations (noticeable pounding, fluttering or irregular heart beat) and pre-syncope (near blackout) are common ED problems sometimes due to an abnormal cardiac rhythm.
- Conditions
- Presyncope, Arrhythmias, Cardiac, Tachycardia, Supraventricular, Atrial Fibrillation
- Trial name
- IPED (NCT02783898)
- Testing
- AliveCor Heart Monitor
- Where
- 10 sites in United Kingdom
- Volunteers
- 243 people
- Sponsor
- NHS Lothian
Atrial Flutter, Tachycardia, Supraventricular
Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia
The FAST Trial Registry is a prospective observational cohort study of fetuses with a new diagnosis of atrial flutter (AF) or supraventricular tachycardia (SVT) that is severe enough to consider prenatal treatment (see…
- Conditions
- Atrial Flutter, Tachycardia, Supraventricular, Tachycardia, Atrial Ectopic, Tachycardia, Reciprocating
- Trial name
- FAST Registry (NCT03376438)
- Testing
- Prospective observational cohorts
- Where
- 41 sites in United States, Australia and 12 more
- Volunteers
- 330 people
- Sponsor
- Edgar Jaeggi
Tachycardia, Atrioventricular Nodal Reentry
AV Nodal Reentrant Tachycardia Study
The purpose of this study is to determine/identify what mechanisms/factors are involved with regard to AV nodal reentrant tachycardia.
- Trial name
- AVNRT (NCT00618683)
- Testing
- Cardiac Invasive Electrophysiological Study
- Where
- United States
- Volunteers
- 46 people
- Sponsor
- University of Oklahoma
Supraventricular Tachycardia
Multicenter Study of Antiarrhythmic Medications for Treatment of Infants With Supraventricular Tachycardia
This is a randomized, double-blind, multi-centered study to compare 6 months of medical treatment with digoxin or propranolol in infants with SVT Background: SVT is the most common sustained arrhythmia of infancy.
- Trial name
- NCT00390546
- Testing
- Digoxin, Propranolol
- Where
- 14 sites in United States, Canada
- Volunteers
- 72 people
- Sponsor
- University of British Columbia
Arrhythmia, Bradycardia
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival…
- Conditions
- Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia
- Trial name
- PPR (NCT00271180)
- Testing
- Device
- Where
- 338 sites in United States, Australia and 33 more
- Volunteers
- 20,000 people
- Sponsor
- Medtronic
Supraventricular Tachycardia
Management of Supraventricular Tachycardia of Children
Supraventricular tachycardia (SVT) is defined as an abnormally rapid heart rhythm originating above the ventricles. It usually has narrow complex tachycardia but this is not always the case.
- Trial name
- NCT03528616
- Testing
- adenosine,Propranolol,flecainide, amiodarone, propranolol, digoxin and procainamide.
- Volunteers
- 50 people
- Sponsor
- Assiut University
Arrhythmias, Cardiac, Tachycardia, Supraventricular
Cardiac Arrhythmias in Pediatric Emergency Department
This cross-sectional study aims to determine the incidence, clinical presentation, and outcome of cardiac arrhythmias among children presenting to the Emergency Department of Assiut University Children Hospital.
- Conditions
- Arrhythmias, Cardiac, Tachycardia, Supraventricular, Bradycardia
- Trial name
- NCT07826273
- Volunteers
- 73 people
- Sponsor
- Assiut University
Cardiovascular Diseases, Heart Diseases
Epidemiology of Symptomatic Arrhythmias
To acquire a better understanding of the spontaneous clinical behavior of paroxysmal tachycardia by studying epidemiologic features of symptomatic tachycardia patients.
- Conditions
- Cardiovascular Diseases, Heart Diseases, Atrial Fibrillation, Arrhythmia
- Trial name
- NCT00005237
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)